Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
Table 2
Clinical characteristics of the diabetic retinopathy patients (DR) with diabetic macular edema (DME) or proliferative retinopathy (PDR). The data are expressed as mean (standard deviation (SD)) or (percent (%)).
DME
PDR
Age (years)
63.6 (10.2)
55.4 (15.1)
<0.001
Gender
0.272
Women
29 (44.6%)
27 (35.5%)
Men
36 (55.4%)
49 (64.5%)
BMI (kg/m2)
30.1 (5.8)
28.2 (5.6)
0.057
Diabetes
<0.001
Type 1
18 (27.7%)
46 (60.59%)
Type 2
47 (72.3%)
30 (39.5%)
Duration
22.1 (9.5)
24.9 (10.2)
0.095
BP systolic (mmHg)
145.4 (24.1)
152.2 (20.6)
0.448
BP diastolic (mmHg)
78.3 (7.1)
83.9 (13.9)
0.305
Nephropathy
15 (23.8%)
30 (42.9%)
0.020
Neuropathy
21 (33.9%)
32 (46.4%)
0.145
Hypertension
54 (84.4%)
55 (78.6%)
0.389
Cholesterol (mMol)
4.6 (1.1)
4.7 (1.1)
0.496
LDL (mMol)
2.7 (0.9)
2.8 (0.9)
0.737
HDL (mMol)
1.3 (0.3)
1.3 (0.4)
0.966
Triglycerides (mMol)
1.5 (1.0)
2.0 (1.7)
0.086
Creatinine (μMol)
91.6 (64.2)
114.0 (103.7)
0.124
Glucose (mMol)
8.9 (3.9)
9.3 (3.9)
0.521
HbA1c (%)
9.2 (2.1)
9.1 (1.7)
0.657
BMI: body mass index, BP: blood pressure, HbA1c: glycated hemoglobin, HDL: high-density lipoprotein, and LDL: low-density lipoprotein.
